Download PDF
Thorac Cardiovasc Surg
DOI: 10.1055/a-2132-4694
Short Communications

Implanting Impella 5.5 under Local Anesthesia

Kaveh Eghbalzadeh 
1   Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany
,
Thorsten C.W. Wahlers
1   Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany
,
Antje Christin Deppe
1   Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany
› Author Affiliations
› Further Information
    Permissions and Reprints All articles of this category

Abstract

Background Surgically implanted Impella 5.5. delivers full cardiac support and left ventricular unloading for patients with heart failure. So far, the Impella device is implanted under general anesthesia (GA).

Material and Methods A total of n = 3 critically ill patients presented with acute heart failure in need of cardiac support. All patients suffered cardiogenic shock of varying etiology. Due to hemodynamically unstable conditions, GA was avoided. All implantations were performed solely under local anesthesia (LAS) without any regional anesthesia.

Results All implantations were performed successfully under LAS with 60 mL of mepivacaine of 2% solution and ropivacaine of 1% solution (50:50 ratio). All devices were placed from the right axillary artery. One patient needed hematoma evacuation several days after surgery. No other Impella-related complication was observed.

Conclusion A surgical implantation of the Impella 5.5 device under LAS is feasible and safe. Despite the small number of cases, no disadvantage can be described at the present moment. Our series should encourage physicians to perform the procedure under LAS.

Keywords

circulatory assist devices - heart failure - transplantation - heart - cardiomyopathy


Publication History

Received: 20 May 2023

Accepted: 17 July 2023

Accepted Manuscript online:
18 July 2023

Article published online:
11 August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Ramzy D, Soltesz E, Anderson M. New surgical circulatory support system outcomes. ASAIO J 2020; 66 (07) 746-752
    CrossrefPubMedGoogle Scholar
  • 2 Anderson M, Smith D, Kane P, Lee R, Khalpey Z, Williams J. Impella 5.5 direct aortic implant and explant techniques. Ann Thorac Surg 2021; 111 (05) e373-e375
    CrossrefPubMedGoogle Scholar
  • 3 Ooms JF, Van Wiechen MP, Hokken TW. et al. Simplified trans-axillary aortic valve replacement under local anesthesia—a single-center early experience. Cardiovasc Revasc Med 2021; 23: 7-13
    CrossrefPubMedGoogle Scholar
  • 4 Ehret C, Rossaint R, Foldenauer AC. et al. Is local anaesthesia a favourable approach for transcatheter aortic valve implantation? A systematic review and meta-analysis comparing local and general anaesthesia. BMJ Open 2017; 7 (09) e016321
    CrossrefPubMedGoogle Scholar
  • 5 Coyan G, Anand N, Imran M. et al. ECMO and Impella support strategies as a bridge to surgical repair of post-infarction ventricular septal rupture. Medicina (Kaunas) 2022; 58 (05) 611
    CrossrefPubMedGoogle Scholar
  • 6 Ruiz Duque E, Hohenwarter MR, Isom NR, Singhal AK. Impella support for surgical ventricular septal defect repair. ASAIO J 2023; 69 (06) e278-e283
    CrossrefPubMedGoogle Scholar
  • 7 Hoeper MMBR, Benza RL, Corris P. et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J 2019; 53 (01) 1801906
    CrossrefPubMedGoogle Scholar
  • 8 Via G, Buson S, Tavazzi G. et al. Early cardiac unloading with ImpellaCP™ in acute myocardial infarction with ventricular septal defect. ESC Heart Fail 2020; 7 (02) 708-713
    CrossrefPubMedGoogle Scholar